NEWCELLS BIOTECH LIMITED
In administrationKey figures
NEWCELLS BIOTECH LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.
Ratios
2024/25Summary: NEWCELLS BIOTECH LIMITED
What kind of company is it?
NEWCELLS BIOTECH LIMITED is a private limited company registered with Companies House under company number 09389592. It was incorporated on 15 Jan 2015. Its status at Companies House is: in administration. The registered office is in Manchester (M1). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
How is the company doing financially?
The latest accounts in the database are for 2024/25 (period ending 31 Jan 2025); the company files small company accounts. Loss for the year was £3,564,336. Net assets were £73,312, down 98% on the previous year. Cash at bank and in hand was £612,060. Total assets were £2,609,027 and total liabilities £2,535,715. The company had an average of 47 employees. Figures are available for 5 financial years (2020/21–2024/25).
Has it received government grants?
It is recorded as the recipient of 2 central government grants worth £141.4k, from Department for Science, Innovation and Technology.
What do public registers and reports show?
HMRC lists it as an importer of goods, mainly miscellaneous chemicals, organic chemicals, pharmaceuticals. HMRC lists it as an exporter of goods, mainly pharmaceuticals.
Who runs and controls the company?
3 persons with significant control are registered. 1 of 2 registered charges are outstanding.
Control structure
Click a box to see its connections.
From the Companies House PSC register: who controls NEWCELLS BIOTECH LIMITED and which UK companies it controls. The register gives bands (for example 25–50% of shares or votes), not exact holdings. A company can be opened only when its number and name match the register; individuals and overseas owners are shown by name only.
Filed accounts2020/21–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Profit for the year | -1,132,048 | -2,092,103 | -2,522,510 | -2,491,653 | -3,564,336 |
| Cash at bank and in hand | 5,012,703 | 1,884,565 | 2,222,434 | 2,131,997 | 612,060 |
| Total assets | 6,153,500 | 3,664,294 | 4,336,945 | 4,639,124 | 2,609,027 |
| Total liabilities | 1,231,286 | 831,183 | 3,619,256 | 1,001,476 | 2,535,715 |
| Net assets / total equity | 4,922,214 | 2,833,111 | 717,689 | 3,637,648 | 73,312 |
| Average number of employees | 22 | 35 | 42 | 44 | 47 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Government grants
2 grantsNEWCELLS BIOTECH LIMITED is recorded as the recipient of 2 central government grants since 2023, together worth £141.4k.
- CASERPINADepartment for Science, Innovation and Technology · £38,465 · UKRI - Innovate UK - Scheme
- CASERPINADepartment for Science, Innovation and Technology · £102,888 · UKRI - Innovate UK - Scheme
From the Government Grants Register published by the Cabinet Office (financial years 2016/17 onwards, Open Government Licence v3.0). It covers grants from central government departments and their agencies where the register states the recipient's company number and the recipient name matches this company; grants from local authorities, lottery distributors and devolved governments are not included.
Registers and licences
Listed by HMRC as an importer of goods in 4 of the last 12 months on record, most recently December 2025. Main goods: miscellaneous chemicals, organic chemicals, pharmaceuticals and plastics.
Listed by HMRC as an exporter of goods in 5 of the last 12 months on record, most recently February 2026. Main goods: pharmaceuticals.
From HMRC's monthly lists of importers and exporters. Traders can ask to be left off the lists, so absence does not mean a company does not trade.
Sources: Charity Commission for England and Wales, Care Quality Commission, Home Office and HM Revenue & Customs, under the Open Government Licence v3.0. Entries marked ‡ come from lists that do not state a company number and were linked by an exact match on the registered name.
History
13 events- Financial year 2024/25 endedAccounts: net assets £73.3k, 47 employees
- Financial year 2023/24 endedAccounts: net assets £3.6m, 44 employees
- Financial year 2022/23 endedAccounts: net assets £717.7k, 42 employees
- Financial year 2021/22 endedAccounts: net assets £2.8m, 35 employees
- Financial year 2020/21 endedAccounts: net assets £4.9m, 22 employees
- Mercia Fund Management Limited registered as a person with significant control
- Nvm Private Equity Llp registered as a person with significant control
- Nvm Private Equity Llp ceased to be a person with significant control
Earlier events (5)
- Professor Lyle Armstrong ceased to be a person with significant control
- North East Accelerator General Partner Limited registered as a person with significant control
- Northstar Ventures Limited registered as a person with significant control
- Professor Lyle Armstrong registered as a person with significant control
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.